ZIM
SPPI

Zacks Investment Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Zacks Investment Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40,256
Closed -$17K – 684
2022
Q3 		$17K Buy
+40,256
New +$39.6K ﹤0.01% 574
2022
Q2 		– Sell
-44,292
Closed -$57K – 674
2022
Q1 		$57K Buy
+44,292
New +$40.8K ﹤0.01% 582
2020
Q1 		– Sell
-58,650
Closed -$213K – 616
2019
Q4 		$213K Buy
+58,650
New +$474K ﹤0.01% 513
2016
Q1 		– Sell
-34,456
Closed -$208K – 703
2015
Q4 		$208K Buy
+34,456
New +$197K 0.01% 521

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Zacks Investment Management's SPPI Position: Q4 2022 in Review

Zacks Investment Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2022, closing a stake of 40,256 shares — an estimated $17K sold.

Zacks Investment Management first reported a position in SPPI in Q4 2015 and held it in 4 quarters. The position peaked at $213K in Q4 2019. 70 funds tracked by Wall St. Rank hold SPPI as of Q4 2022.

  • Zacks Investment Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2022 after selling out during the quarter.
  • Zacks Investment Management sold 40,256 Spectrum Pharmaceuticals Inc shares in Q4 2022, an estimated $17K.
  • Zacks Investment Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2015 and held it in 4 quarters.
  • Zacks Investment Management's Spectrum Pharmaceuticals Inc position peaked at $213K in Q4 2019.
  • 70 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2022.

Based on Zacks Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.